Página 2 - Melhores Astrocitoma médicos - TOP-61 médicos

A Prof.ª Elke Jaeger realizou mais de 1.100 procedimentos oncológicos e é classificada como uma das melhores oncologistas da Alemanha há 20 anos.

• Chefe de Oncologia e Hematologia na Clínica Nordwest
• Especializar-se no tratamento de sarcomas
• Professora de oncologia médica e hemato-oncologia
• Membro da comissão de especialistas da EORTC

O Dr. Felix Bokstein lidera a Clínica de Neuro-oncologia no Ichilov – um dos maiores e mais avançados hospitais de Israel, com foco específico em tumores cerebrais.

• O seu foco principal é o tratamento de tumores complexos do cérebro e da medula espinhal.
• Como chefe da clínica, supervisiona uma unidade dedicada à neuro-oncologia.
• A sua experiência inclui a gestão de gliomas, astrocitomas e outras neoplasias malignas do SNC.
• Integra quimioterapia, terapias direcionadas e opções de ensaios clínicos nos planos de tratamento.

Especializado em astrocitoma e formado nas principais instituições médicas turcas – o Dr. Alemdar traz cuidados oncológicos baseados em evidências para o Complexo Hospitalar Medical Park Antalya.

• Ter concluído a formação em oncologia médica na Universidade de Akdeniz
• Mais de 14 anos tratando câncer em ambientes hospitalares e universitários
• Vasta experiência em hospitais de ensino e pesquisa
• Trabalhar ao lado de equipas multidisciplinares para um tratamento abrangente

O Professor Zvi Ram chefia a Associação Europeia de Sociedades Neurocirúrgicas (EANS) – um cargo de alto nível que destaca a sua liderança na área.

• Especializar-se em cirurgia minimamente invasiva e técnicas de mapeamento cerebral
• Ser especialista em operações neurocirúrgicas, incluindo estimulação cerebral profunda (DBS)
• Realizar neurocirurgia guiada por imagem para tumores cerebrais, formado na Grécia e na Suíça
• Liderar pesquisas em terapias de base genética para cancro cerebral
• Ser distinguido com o Prémio Borenstein da Brain & Behavior Research Foundation

O Dr. Yildiz publicou extensivamente sobre tumores neuroendócrinos e casos oncológicos raros, com pesquisas apresentadas em revistas médicas internacionais.

• Especializar-se em tumores neuroendócrinos e apresentações raras de cancro
• Publicar mais de 17 artigos revistos por pares sobre temas oncológicos
• Trabalhar no Hospital Universitário Medipol Mega

O Prof. Wolfgang Köstler é especialista em terapias oncológicas direcionadas, com foco em malignidades mamárias e ginecológicas na Wiener Privatklinik.

• Mais de 20 anos de experiência em oncologia médica
• Especialista em desenvolvimento de biomarcadores e biologia tumoral
• Professor Associado na Universidade Médica de Viena
• Chefe Adjunto da Divisão Clínica de Oncologia

O Professor Associado Tahsin Ozatli é especialista em cancro da mama, do pulmão e gastrointestinal no Hospital Universitário Istinye Liv.

• Especialista em Medicina Interna com vasta experiência em oncologia
• Exerceu na Clínica de Oncologia de Ancara e no Hospital Regional de Formação de Erzurum
• Licenciado pela Faculdade de Medicina da Universidade de Selcuk
• Promovido a Professor Associado em 2016

Médica-chefe em um centro oncológico interdisciplinar certificado – a Dra. Viola Fox é especialista em tratamentos avançados para astrocitoma.

• Especialista em quimioterapia, imunoterapia e terapia-alvo
• Especialista qualificada em genética com experiência em diagnóstico molecular
• Ativa em pesquisa de biologia molecular para tratamentos inovadores contra o câncer
• Membro de sociedades de oncologia alemãs e americanas

O Professor Keil é especializado em imagens avançadas e intervenções para astrocitoma no Centro Médico de Solingen.

• Mais de 16 anos em radiologia diagnóstica e intervencionista
• Formol-se sob a orientação da renomada radiologista Professora Christiane K. Kuhl
• Especialista em ressonância magnética, tomografia computadorizada e intervenções guiadas por ultrassom
• Atual médico-chefe de radiologia diagnóstica e intervencionista

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

O Prof. Adjunto Nail Paksoy traz ampla experiência em oncologia médica, especializando-se em tratamentos de astrocitoma na Universidade Medipol de Istambul.

• Certificado pelo Conselho da ESMO em Oncologia Médica
• Participante ativo em ensaios clínicos internacionais para tratamentos de cancro
• Publicar inúmeros artigos de investigação sobre terapias oncológicas inovadoras

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Definição dos primeiros critérios rigorosos para o diagnóstico de síndromes neurológicas paraneoplásicas – um avanço fundamental na neuro-oncologia. O Dr. Graus é investigador emérito no IDIBAPS.

• Ex-chefe de neurologia no Hospital Clínic, Barcelona
• Fundador e ex-presidente da Associação Europeia de Neuro-Oncologia
• Doutorado pela Universitat Autònoma de Barcelona
• Especializar-se em gliomas e linfomas cerebrais primários

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.